CAV1 and lung adenocarcinoma: Gastric cancer patients who express caveolin-1 have been shown to have poor progression-free survival[133], and its expression has been found to contribute to tumor progression and metastasis in lung adenocarcinoma cell lines, with a positive correlation with the tumor stage[134].